Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription 06.12.2021 1 Am J Respir Crit Care Med 1 Ann Oncol 6 Ann Thorac Surg 1 BMC Cancer 2 Br J Cancer 1 Chest 1 Clin Cancer Res 1 Clin Exp Metastasis 3 Clin Lung Cancer 1 Eur J Cancer 1 Eur J Cardiothorac Surg 2 Int J Radiat Oncol Biol Phys 1 J Cancer Res Clin Oncol 1 J Clin Oncol 4 Lancet Oncol 4 PLoS One 2 Proc Natl Acad Sci U S A 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. GESTHALTER YB, Seeley EJ
   Lung Cancer Screening.
   Am J Respir Crit Care Med. 2021;204:P19-P20.
   PubMed        
   
   

   
   Ann Oncol

2. ATTILI I, Passaro A, de Marinis F
   Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer: limits and potentials.
   Ann Oncol. 2021 Nov 25. pii: S0923-7534(21)04823.
   PubMed        
   
   

   
   Ann Thorac Surg

3. MYNARD JN, Port JL
   Mediastinal Repositioning for Postpneumonectomy Syndrome.
   Ann Thorac Surg. 2021;112:e473.
   PubMed        
   
   
4. ROSENFELD ES, Napolitano MA, Sparks AD, Werba G, et al
   Impact of Trainee Involvement on Video-Assisted Thoracoscopic Lobectomy for Cancer.
   Ann Thorac Surg. 2021;112:1855-1861.
   PubMed         Abstract available
   
   
5. KOBAYASHI AK, Nakagawa K, Nakayama Y, Ohe Y, et al
   Salvage Surgery Compared to Surgery After Induction Chemoradiation Therapy for Advanced Lung Cancer.
   Ann Thorac Surg. 2021 Nov 26. pii: S0003-4975(21)01985.
   PubMed         Abstract available
   
   
6. YAO F, Wu W, Zhu Q, Zhai R, et al
   Thoracoscopic Pulmonary Segmentectomy With Collateral Ventilation Method.
   Ann Thorac Surg. 2021;112:1814-1823.
   PubMed         Abstract available
   
   
7. SCHIAVON M, Comacchio GM, Mammana M, Faccioli E, et al
   Lobectomy With Artery Reconstruction and Pneumonectomy for Non-Small Cell Lung Cancer: A Propensity Score Weighting Study.
   Ann Thorac Surg. 2021;112:1805-1813.
   PubMed         Abstract available
   
   
8. NOBEL TB, Sihag S, Xing XX, Eljalby M, et al
   Oligometastases After Curative Esophagectomy Are Not One-Size-Fits-All.
   Ann Thorac Surg. 2021 Mar 6. pii: S0003-4975(21)00454.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. MA HC, Liu YH, Ding KL, Liu YF, et al
   Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials.
   BMC Cancer. 2021;21:1278.
   PubMed         Abstract available
   
   

   
   Br J Cancer

10. CAMINA N, Penning TM
    Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.
    Br J Cancer. 2021 Nov 29. pii: 10.1038/s41416-021-01642.
    PubMed         Abstract available
    
    
11. TAMMINGA M, Andree KC, van den Bos H, Hiltermann TJN, et al
    Leukapheresis increases circulating tumour cell yield in non-small cell lung cancer, counts related to tumour response and survival.
    Br J Cancer. 2021 Nov 30. pii: 10.1038/s41416-021-01634.
    PubMed         Abstract available
    
    

    
    Chest

12. PINSKY PF, Lynch DA, Gierada DS
    Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04413-5. doi: 10.1016/j.chest.2021.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

13. XIA L, Mei J, Kang R, Deng S, et al
    Perioperative ctDNA-based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1).
    Clin Cancer Res. 2021 Nov 29. pii: 1078-0432.CCR-21-3044.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

14. SHI X, Huang X, Chen R, Li Y, et al
    The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO.
    Clin Exp Metastasis. 2021 Oct 29. pii: 10.1007/s10585-021-10128.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

15. GARON EB, Peterson P, Rizzo MT, Kim JS, et al
    Overall Survival and Safety With Pemetrexed/Platinum +/- Anti-VEGF Followed by Pemetrexed +/- Anti-VEGF Maintenance in Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies.
    Clin Lung Cancer. 2021 Oct 25. pii: S1525-7304(21)00274.
    PubMed         Abstract available
    
    
16. SONODA D, Matsuura Y, Kondo Y, Ichinose J, et al
    A Reasonable Definition of Oligo-Recurrence in Non-Small-Cell Lung Cancer.
    Clin Lung Cancer. 2021 Oct 25. pii: S1525-7304(21)00276.
    PubMed         Abstract available
    
    
17. HELLYER JA, White MN, Gardner RM, Cunanan K, et al
    Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer.
    Clin Lung Cancer. 2021 Oct 21. pii: S1525-7304(21)00245.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

18. PERALTA-ARRIETA I, Trejo-Villegas OA, Armas-Lopez L, Ceja-Rangel HA, et al
    Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.
    Eur J Cancer. 2021 Nov 26. pii: S0959-8049(21)01190.
    PubMed         Abstract available
    
    

    
    Eur J Cardiothorac Surg

19. DRAWBERT HE, Hey MT, Tarrazzi F, Block M, et al
    Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.
    Eur J Cardiothorac Surg. 2021 Nov 29. pii: 6445266. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

20. WILKIE JR, Hochstedler KA, Schipper MJ, Matuszak MM, et al
    Association Between Physician and Patient Reported Symptoms in Patients Treated with Definitive Radiotherapy for Locally Advanced Lung Cancer in a Statewide Consortium.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03222.
    PubMed         Abstract available
    
    
21. UEKI K, Matsuo Y, Takeda A, Morita S, et al
    Impact of local recurrence on cause-specific death after stereotactic body radiotherapy for early-stage non-small cell lung cancer: dynamic prediction using landmark model.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03223.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

22. NEUMANN JM, Freitag H, Hartmann JS, Niehaus K, et al
    Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.
    J Cancer Res Clin Oncol. 2021 Nov 28. pii: 10.1007/s00432-021-03834.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

23. LE X, Cornelissen R, Garassino M, Clarke JM, et al
    Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.
    J Clin Oncol. 2021 Nov 29:JCO2101323. doi: 10.1200/JCO.21.01323.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

24. KASHIHARA T
    SABR for operable stage I non-small-cell lung cancer: comparison to surgery.
    Lancet Oncol. 2021;22:e534.
    PubMed        
    
    
25. LUO MS
    SABR for operable stage I non-small-cell lung cancer: comparison to surgery.
    Lancet Oncol. 2021;22:e535.
    PubMed        
    
    
26. ZHANG J, Liu L, Zhao K, Guo C, et al
    SABR for operable stage I non-small-cell lung cancer: comparison to surgery.
    Lancet Oncol. 2021;22:e536.
    PubMed        
    
    
27. CHANG JY, Verma V, Feng L, Roth JA, et al
    SABR for operable stage I non-small-cell lung cancer: comparison to surgery - Authors' reply.
    Lancet Oncol. 2021;22:e537-e538.
    PubMed        
    
    

    
    PLoS One

28. RICE SJ, Belani CP
    Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer.
    PLoS One. 2021;16:e0260988.
    PubMed         Abstract available
    
    
29. YANG CZ, Hu LH, Huang ZY, Deng L, et al
    Comprehensive analysis of an immune infiltrate-related competitive endogenous RNA network reveals potential prognostic biomarkers for non-small cell lung cancer.
    PLoS One. 2021;16:e0260720.
    PubMed         Abstract available
    
    
30. BRASSARD J, Gill ME, Bernatchez E, Desjardins V, et al
    Countering the advert effects of lung cancer on the anticancer potential of dendritic cell populations reinstates sensitivity to anti-PD-1 therapy.
    PLoS One. 2021;16:e0260636.
    PubMed         Abstract available
    
    
31. CHOI W, Lee H
    Identifying disease-gene associations using a convolutional neural network-based model by embedding a biological knowledge graph with entity descriptions.
    PLoS One. 2021;16:e0258626.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. SANCHEZ-RIVERA FJ, Ryan J, Soto-Feliciano YM, Clare Beytagh M, et al
    Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
33. WAN PK, Tong KC, Lok CN, Zhang C, et al
    Platinum(II) N-heterocyclic carbene complexes arrest metastatic tumor growth.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

    
    Thorax

34. LEEM G, Jeon M, Kim KW, Jeong S, et al
    Tumour-infiltrating bystander CD8(+) T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217001.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: